SEQMRD Trademark

Trademark Overview

On Monday, October 19, 2020, a trademark application was filed for SEQMRD with the United States Patent and Trademark Office. The USPTO has given the SEQMRD trademark a serial number of 90264063. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 4, 2024. This trademark is owned by HEMATOGENIX LABORATORY SERVICES, LLC. The SEQMRD trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical testing for diagnostic or treatment purposes; Medical testing services, namely, next-generation sequencing testing for detection and diagnosis of blood, bone marrow, and lymph node cancers, namely, leukemias and lymphomas
seqmrd

General Information

Serial Number90264063
Word MarkSEQMRD
Filing DateMonday, October 19, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 4, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 1, 2021

Trademark Statements

Goods and ServicesMedical testing for diagnostic or treatment purposes; Medical testing services, namely, next-generation sequencing testing for detection and diagnosis of blood, bone marrow, and lymph node cancers, namely, leukemias and lymphomas

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, December 8, 2020
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameHEMATOGENIX LABORATORY SERVICES, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressTINLEY PARK, IL 60487
Party NameHEMATOGENIX LABORATORY SERVICES, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressTINLEY PARK, IL 60487

Trademark Events

Event DateEvent Description
Monday, March 4, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 4, 2024ABANDONMENT - NO USE STATEMENT FILED
Wednesday, November 29, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 29, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 29, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, July 22, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 20, 2023SOU EXTENSION 4 GRANTED
Thursday, July 20, 2023SOU EXTENSION 4 FILED
Thursday, July 20, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, January 24, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 20, 2023SOU EXTENSION 3 GRANTED
Friday, January 20, 2023SOU EXTENSION 3 FILED
Friday, January 20, 2023SOU TEAS EXTENSION RECEIVED
Friday, July 29, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 27, 2022SOU EXTENSION 2 GRANTED
Wednesday, July 27, 2022SOU EXTENSION 2 FILED
Wednesday, July 27, 2022SOU TEAS EXTENSION RECEIVED
Saturday, January 22, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 20, 2022SOU EXTENSION 1 GRANTED
Thursday, January 20, 2022SOU EXTENSION 1 FILED
Thursday, January 20, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, July 27, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 1, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 1, 2021PUBLISHED FOR OPPOSITION
Wednesday, May 12, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 27, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 25, 2021EXAMINER'S AMENDMENT ENTERED
Thursday, March 25, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, March 25, 2021EXAMINERS AMENDMENT E-MAILED
Thursday, March 25, 2021EXAMINERS AMENDMENT -WRITTEN
Thursday, March 18, 2021ASSIGNED TO EXAMINER
Tuesday, December 8, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 22, 2020NEW APPLICATION ENTERED

Related Keywords

seqmrd testing medical namely lymph bone marrow node lymphomas leukemias cancers